RETRACTED: Lung Abnormalities in Liver Cirrhosis

Authors

  • Muli Yaman Department of Pulmonology and Respiratory Medicine Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
  • Syifa Mustika Division of Gastroenterohepatology, Department of Internal Medicine,Universitas Brawijaya – RSUD Dr. Saiful Anwar Malang, Indonesia https://orcid.org/0000-0003-4831-2719

DOI:

https://doi.org/10.21776/ub.crjim.2023.004.02.06

Keywords:

Cirrhosis Hepatis, Hepatopulmonary Syndrome, Portopulmonary Hypertension, Hepatic Hydrothorax, Spontaneous Bacterial Empyema

Abstract

Clinical and Research Journal in Internal Medicne has retracted article titled: "Lung Abnormalities in Liver Cirrhosis" by Muli Yaman, and Syifa Mustika, from Vol. 4, No. 2 (2023) since there has been similar publication found in Current Internal Medicine Research and Practice Surabaya Journal (CIMRJ) Vol. 4, No. 1 (January 2023).This retraction announcement is necessary to maintain publication ethics.

References

Bashar S, John S. Hepatic Cirrhosis. StatPearls. [Internet] 2022 [cited 2023 Mar 9]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482419/

Bansal K, S Gore, Mittal S. Hepatopulmonary Syndrome. StatPearls. [Internet] 2022 [cited 2023 Mar 6]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562169/

Benz F, Mohr R, Tacke F, Roderburg C. Pulmonary complications in patients with liver cirrhosis. J Transl Intern Med. 2020;8(3):150–8.

Soulaidopoulos S, Goulis I, Cholongitas E. Pulmonary manifestations of chronic liver disease: A comprehensive review. Ann Gastroenterol. 2020;33(3):237–49.

Shenoda B, Boselli J. Vascular syndromes in liver cirrhosis. Clin J Gastroenterol. [Internet] 2019 [cited 2023 Mar 8] ;12(5):387–97. Available from: http://dx.doi.org/10.1007/s12328-019-00956-0

Menteri Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/15/2023. Keputusan Menteri Kesehatan Republik Indonesia. 2023.

Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison’s Gastroenterology and Hepatology. Mc Graw Hill Education. 2017. 456–470 p.

Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359–76.

Berumen J, Baglieri J, Kisseleva T, Mekeel K. Liver fibrosis: Pathophysiology and clinical implications. WIREs Mech Dis. 2021;13(1):1–17.

Engelmann C, Clària J, Szabo G, Bosch J, Bernardi M. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol. 2021;75(Suppl 1):S49–66.

Slevin E, Baiocchi L, Wu N, Ekser B, Sato K, Lin E, et al. Kupffer Cells: Inflammation Pathways and Cell-Cell Interactions in Alcohol-Associated Liver Disease. Am J Pathol. [Internet] 2020 [cited 2023 Mar 7] ;190(11):2185–93. Available from: https://doi.org/10.1016/j.ajpath.2020.08.014

Meseeha M, Attia M. Esophageal Varics. Pubmed Cent. [Internet] 2022 [cited 2023 Mar 9]; Available from: https://pubmed.ncbi.nlm.nih.gov/28846255/

Iqbal S, Smith KA, Khungar V. Hepatopulmonary Syndrome and Portopulmonary Hypertension: Implications for Liver Transplantation. Clin Chest Med. 2020;38(4):785–95.

Thomas C, Glinskii V, de Jesus Perez V, Sahay S. Portopulmonary Hypertension: From Bench to Bedside. Front Med. 2020;7(November):1–12.

Matyas C, Haskó G, Liaudet L, Trojnar E, Pacher P. Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications. Nat Rev Cardiol. 2021;18(2):117–35.

Raevens S, Boret M, De Pauw M, Fallon MB, Van Vlierberghe H. Pulmonary Abnormalities in Liver Disease: Relevance to Transplantation and Outcome. Vol. 74, Hepatology. 2021. 1674–1686 p.

Cartin-Ceba R, Burger C, Swanson K, Vargas H, Aqel B, Keaveny AP, et al. Clinical Outcomes after Liver Transplantation in Patients with Portopulmonary Hypertension. Transplantation. 2021;105(10):2283–90.

Tokushige K, Kogiso T, Egawa H. Current Therapy and Liver Transplantation for Portopulmonary Hypertension in Japan. J Clin Med. 2023;12(2):562.

Dubrock H, Runo JR, Sadd CJ, Burger C, Cartin-Ceba R, Rosen C, et al. Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm Hg. Pubmed Cent. [Internet] 2020 [cited 2023 Mar 6];6(12). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665265/

Li J, Zhuang Q, Zhang X, Zheng Y, Qiao Z, Zhang J, et al. Prevalence and prognosis of portopulmonary hypertension in 223 Liver Transplant recipients. Can Respir J. 2018;2018.

Lv Y, Han G, Fan D. Hepatic hydrothorax. Ann Hepatol. 2018;17(1):33–46.

Downloads

Published

2023-11-25

How to Cite

Muli Yaman, & Mustika, S. (2023). RETRACTED: Lung Abnormalities in Liver Cirrhosis. Clinical and Research Journal in Internal Medicine, 4(2), 470–480. https://doi.org/10.21776/ub.crjim.2023.004.02.06

Issue

Vol. 4 No. 2 (2023): Volume 4 No 2, November 2023

Section

Review Article

License

Copyright (c) 2023 Clinical and Research Journal in Internal Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The copyright of the received article shall be assigned to the journal as the publisher of the journal. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.